Shareholders of Aurora Cannabis (NYSE: ACB) were dealt an unexpected blow this week as the pot company's disappointing earnings report thwarted hopes
Aurora Cannabis (ACB) banks on premium brands after disastrous Q4
Categories
Cannabis
Highlights of Aurora Cannabis (ACB) Q4 2020 earnings report
Aurora Cannabis, Inc. (NYSE: ACB) reported a wider loss for the fourth quarter of 2020, hurt by a 5% decrease in revenues.
During tough times, Tilray (TLRY) looks overseas to achieve growth targets
Cannabis was recognized as an essential business in several markets when the shutdown came into effect, including Canada and some US states,
GW Pharmaceuticals PLC (GWPH) Q2 2020 Earnings Call Transcript
GW Pharmaceuticals PLC (NASDAQ: GWPH) Q2 2020 earnings call dated August 06, 2020 Corporate Participants: Stephen Schultz -- Vice President of Investor Relations Justin
Canopy Growth’s (CGC) net loss narrows in Q1 on revenue growth and cost cuts; stock surges
After Canopy Growth (NYSE: CGC) reported its first quarter 2021 results yesterday, the shares jumped about 10% in the pre-market trading and
Tilray Q2 loss widens despite revenue growth; results miss
https://www.youtube.com/watch?v=KqNZ-_X4F8k&t=2s Cannabis company Tilray, Inc. (NASDAQ: TLRY) Monday reported a wider net loss for the second quarter of 2020, despite a marked
Canopy Growth (CGC) Q1 2021 earnings in a nutshell
Canopy Growth (NYSE: CGC) reported an improvement in net loss for its first quarter ended 2021 with a revenue increase of 22%.
Cronos (CRON) Q2 Earnings: Key financials and quarterly highlights
Cronos Group Inc. (NASDAQ: CRON) reported second quarter 2020 earnings results today. Consolidated net revenues grew 29% year-over-year to $9.9 million, driven
Aphria (APHA) swings to a loss in Q4 despite 18% growth in revenue
Aphria (NASDAQ: APHA) stock plunged more than 10% in the pre-market trading session as it reported a loss of C$98 million or
4Front Ventures Corp (Other OTC: FFNTF) Q4 2019 Earnings Call Transcript
4Front Ventures Corp (FFNTF) Q4 2019 earnings call dated Jun. 15, 2020 Corporate Participants: Andrew Thut -- Chief Investment Officer Leo Gontmakher -- Chief Executive Officer
Neptune Wellness (NEPT) defies COVID crisis and looks to start FY21 on a high note
In several markets, the cannabis industry was less affected by the coronavirus than most other businesses, even as the authorities in some
HEXO Corp. (NYSE: HEXO) Q3 2020 Earnings Call Transcript
HEXO Corp. (HEXO) Q3 2020 earnings call dated June 11, 2020 Corporate Participants: Jennifer Smith -- Director of Investor Relations Sebastien St-Louis -- Co-founder and Chief
Infographic: Key highlights of HEXO Corp (HEXO) Q3 2020 earnings
HEXO Corp. (TSX: HEXO; NYSE: HEXO) reported a wider loss in the third quarter of 2020 due to higher expenses. The top-line
With right product mix and CAPEX discipline, Canopy Growth (CGC) can hit growth path
The latest quarterly performance of Canopy Growth Corporation (NYSE: CGC) was nothing short of a disaster, with the cannabis firm incurring a
Infographic: Highlights of Canopy Growth (CGC) Q4 2020 earnings results
Canopy Growth Corporation (NYSE: CGC) reported its financial results for the quarter ended March 31, 2020, on Friday before the market opens.
Village Farms (VFF): Regulatory uncertainty – a major roadblock for US CBD opportunity
Village Farms International Inc. (NASDAQ: VFF) reported total sales of $39.6 million for the first quarter of 2020 compared to $38.6 million
Infographic: Highlights of Aurora Cannabis (ACB) Q3 2020 Earnings Report
Aurora Cannabis, Inc. (NYSE: ACB) reported a narrower loss for the third quarter of 2020, aided by a 16% growth in revenues.
Arcadia Biosciences (RKDA): GoodHemp forms key part of growth strategy
Arcadia Biosciences (NASDAQ: RKDA) saw its revenues nearly double to $309,000 in the first quarter of 2020 versus the same period a
Tilray’s (TLRY) loss widens in Q1 despite minimal impact from COVID-19
Tilray (NASDAQ: TLRY) reported mixed results yesterday for its first quarter of 2020. Despite revenue rising more than 100% in the quarter,
GW Pharmaceuticals (GWPH): Investments in manufacturing and international expansion serve as strong growth drivers
GW Pharmaceuticals plc (NASDAQ: GWPH) has seen its stock gain over 17% in the past one month. The company delivered topline growth
Tilray Inc (NASDAQ: TLRY) Q1 2020 Earnings Call Transcript
Tilray Inc (TLRY) Q1 2020 earnings call dated May. 11, 2020 Corporate Participants: Raphael Gross -- Investor Relations Brendan Kennedy -- Chief Executive Officer Michael Kruteck -- Chief